San Diego ophthalmic biotech upstart raises $28M on alternative to corneal transplant

San Diego ophthalmic biotech upstart raises $28M on alternative to corneal transplant

Source: 
Endpoints
snippet: 

Texas VC Bios Partners has found a new early-stage play to love out of San Diego, leading a $28 million Series A to help Trefoil Therapeutics make the leap to the clinic.